GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Cell Impact (OSTO:CI) » Definitions » 3-Year EPS without NRI Growth Rate

Cell Impact (OSTO:CI) 3-Year EPS without NRI Growth Rate : -58.50% (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Cell Impact 3-Year EPS without NRI Growth Rate?

Cell Impact's EPS without NRI for the three months ended in Dec. 2023 was kr-0.06.

During the past 3 years, the average EPS without NRI Growth Rate was -58.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was -24.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was -19.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Cell Impact was 33.80% per year. The lowest was -165.30% per year. And the median was -19.80% per year.


Competitive Comparison of Cell Impact's 3-Year EPS without NRI Growth Rate

For the Metal Fabrication subindustry, Cell Impact's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cell Impact's 3-Year EPS without NRI Growth Rate Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Cell Impact's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Cell Impact's 3-Year EPS without NRI Growth Rate falls into.



Cell Impact 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Cell Impact  (OSTO:CI) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Cell Impact 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Cell Impact's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Cell Impact (OSTO:CI) Business Description

Industry
Traded in Other Exchanges
Address
Kallmossvagen 7A, Karlskoga, SWE, 691 52
Cell Impact develops technologies to produce flow plates for fuel cells. It provides graphite, stainless steel, and titanium flow plates. The company has developed and patented a unique method for high-velocity forming, Cell Impact Forming that makes it possible to produce flow plates with more advanced designs, which in turn creates more cost and energy-efficient fuel cells compared to conventional molding methods.

Cell Impact (OSTO:CI) Headlines

From GuruFocus

Q4 2021 Cigna Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2021 Cigna Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2022 Cigna Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Cigna Corp at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-22-2024